Intracavitary perfusion with bevacizumab plus cisplatin versus cisplatin alone for malignant pleural effusion in lung cancer patients: a meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1186/s12957-025-03887-y
Published Online: 2025-07-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, Xiao
Qin, Shuai
Liu, Songjiang
Li, Zhuying
Text and Data Mining valid from 2025-07-14
Version of Record valid from 2025-07-14
Article History
Received: 31 December 2024
Accepted: 5 June 2025
First Online: 14 July 2025
Declarations
:
: Not Applicable.
: Not applicable.
: The authors declare no competing interests.